Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Varun Sharma

Sports Medicine Springfield, IL Medical Doctor

NPI 1447723960 CMS profile 6871764

1301 S Koke Mill Rd, Springfield, IL 62711

Open in the dashboard

General payments

$34,057

294 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Varun Sharma of Springfield, IL is reported in the CMS Open Payments database as having received $34,057 across 294 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,185 13
2024 General $5,945 27
2023 General $6,070 60
2022 General $4,381 37
2021 General $5,216 43
2020 General $3,422 55
2019 General $7,837 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Varun Sharma
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Varun Sharma were reported at $1,185. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Varun Sharma Sports Medicine median Middle half National median
2019 $7,837 $1,176 $199–$4,249 $163
2020 $3,422 $708 $96–$2,890 $114
2021 $5,216 $1,213 $152–$3,994 $132
2022 $4,381 $1,230 $159–$3,998 $149
2023 $6,070 $584 $146–$2,836 $160
2024 $5,945 $628 $163–$3,168 $164
2025 $1,185 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $12,773 133 payments
  2. Zimmer Biomet Holdings, Inc. $9,934 69 payments
  3. Arthrex, Inc. $8,644 78 payments
  4. Wardlow Enterprises $1,414 4 payments
  5. Prism Medical $1,051 1 payment
  6. Globus Medical, Inc. $111 1 payment
  7. Orthofix Medical, Inc. $68 4 payments
  8. Flexion Therapeutics, Inc. $28 2 payments
  9. Kowa Pharmaceuticals America, Inc. $21 1 payment
  10. Ferring Pharmaceuticals Inc. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $18,527 71 payments
  2. Food and Beverage $11,961 218 payments
  3. Education $3,569 5 payments
Products named General payments · program years 2019–2025
  1. Comprehensive Shoulder System $4,168 33 payments
  2. MAKO Knees, Hips $2,930 31 payments
  3. Avenir $1,479 1 payment
  4. PROCINCH $1,408 6 payments
  5. MAKO Knees, Hips $1,275 15 payments
  6. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,261 6 payments
  7. NA $1,185 4 payments
  8. Comprehensive Primary Stem $1,141 10 payments
  9. Persona $1,003 4 payments
  10. T2 $708 1 payment
  11. Other $6,597 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

361

Median for Orthopedic Surgery: 203

Drug cost

$1,496

Median for Orthopedic Surgery: $1,433

Branded share of claims

3.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cyclobenzaprine Hcl Generic 50 $562
Gabapentin Generic 78 $391
Meloxicam Generic 113 $199
Oxycodone Hcl Generic 44 $109
Methylprednisolone Generic 15 $90
Ondansetron Odt Ondansetron Brand 14 $62
Ondansetron Hcl Generic 29 $54
Tizanidine Hcl Generic 18 $30

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 96 billing codes

Paid by Medicare

$160,289

Of which drugs: $1,167

Medicare patients

332

Average age 73

Services billed

2,785

175 women, 157 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 33%
Diabetes 29%
Depression 25%
COPD 21%
Chronic kidney disease 19%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 122 1,596 $1,166

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

294 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record